ezetimibe has been researched along with 3,3',5-triiodothyroacetic acid in 2 studies
| Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (3,3',5-triiodothyroacetic acid) | Trials (3,3',5-triiodothyroacetic acid) | Recent Studies (post-2010) (3,3',5-triiodothyroacetic acid) |
|---|---|---|---|---|---|
| 2,484 | 563 | 1,465 | 255 | 11 | 47 |
| Protein | Taxonomy | ezetimibe (IC50) | 3,3',5-triiodothyroacetic acid (IC50) |
|---|---|---|---|
| Thyroid hormone receptor alpha | Homo sapiens (human) | 0.0001 | |
| Thyroid hormone receptor beta | Rattus norvegicus (Norway rat) | 0.0002 | |
| Sodium/bile acid cotransporter | Homo sapiens (human) | 6.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, S; Chen, Y; Fu, L; Zhang, L | 1 |
1 review(s) available for ezetimibe and 3,3',5-triiodothyroacetic acid
| Article | Year |
|---|---|
Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential.
Topics: Carcinoma, Hepatocellular; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Interferons; Liver Neoplasms; Nucleotides; Organic Anion Transporters, Sodium-Dependent; Symporters; Virus Internalization | 2022 |
1 other study(ies) available for ezetimibe and 3,3',5-triiodothyroacetic acid
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |